Athira Pharma's market cap is currently ―. The company's EPS TTM is $-3.094; its P/E ratio is -0.69; Athira Pharma is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.80. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -32.97M	$ -29.60M	$ -27.98M	$ -29.70M	$ -21.17M
EBITDA	$ -33.07M	$ -29.71M	$ -28.02M	$ -29.77M	$ -20.94M
Net Income Common Stockholders	$ -32.97M	$ -29.60M	$ -27.82M	$ -30.14M	$ -20.74M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 172.95M	$ 186.09M	$ 185.98M	$ 200.34M	$ 220.96M
Total Assets	$ 184.70M	$ 208.05M	$ 232.77M	$ 258.15M	$ 274.19M
Total Debt	$ 1.67M	$ 1.75M	$ 1.83M	$ 1.91M	$ 1.99M
Net Debt	$ -171.28M	$ -184.34M	$ -184.15M	$ -198.43M	$ -218.97M
Total Liabilities	$ 29.94M	$ 23.07M	$ 21.65M	$ 23.02M	$ 11.94M
Stockholders Equity	$ 154.76M	$ 184.98M	$ 211.13M	$ 235.14M	$ 262.25M
Cash Flow	-
Free Cash Flow	$ -24.01M	$ -24.32M	$ -26.43M	$ -15.67M	$ -21.88M
Operating Cash Flow	$ -23.98M	$ -24.28M	$ -26.19M	$ -15.67M	$ -21.64M
Investing Cash Flow	$ 20.69M	$ 32.49M	$ 35.52M	$ 24.65M	$ 13.63M
Financing Cash Flow	-	$ 242.00K	$ 99.00K	$ 147.00K	$ 0.00

Currency in USD

Athira Pharma Earnings and Revenue History

Income Statement >

Athira Pharma Debt to Assets

Balance Sheet >

Athira Pharma Cash Flow

Cash Flow >

Athira Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing